The European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products. 

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the neurostimulation device market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents

  • Neurostimulation Devices - Market Insights - Europe (Supplemental)

Author(s): Sophia Quraishi, BA

Sophia Quraishi is an analyst on the Medtech Insights team at Decision Resources Group and currently serves as the in-house expert in gastroenterology, open surgery, and liquid biopsy markets. Sophia has been instrumental in leveraging medical claims and hospital purchase order data for expanded new areas of investigation within her fields of expertise. Sophia holds a Bachelor's degree in Psychology with a specialization in Neuroscience from Columbia University in the City of New York.  

Related Reports

Neurostimulation Devices - Market Insights - United States

The US neurostimulation device market will grow rapidly, driven by expanding approval of these devices for new indications, increasing demand for non-pharmaceutical treatments, and the...

View Details

Neurosurgical Devices - Market Insights - Europe

While the European neurosurgical device market will be significantly limited by competing treatments, growth will be maintained by continued adoption of premium-priced devices and the advancement...

View Details

Neurosurgical Devices - Market Insights - United States

The US market for neurosurgical devices consists of a mixture of quickly expanding emerging technology markets and relatively mature market segments. This Medtech 360 Report...

View Details